Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?
Schneemann
Markus
M
Bachli
Esther B
EB
D000666:Amphotericin B / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003840:Deoxycholic Acid / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*
D000935:Antifungal Agents; D004338:Drug Combinations; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination